Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LATS1 | O95835 | 11/20 | 0.59 |
| ▸ | LATS2 | Q9NRM7 | 8/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.40 |
| ▸ | ACHE | P22303 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | RAD52 | P43351 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.36 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4251618 | 0.83 | ACHE (0.45) | LATS1LATS2CYP3A4ACHEKDM4E | |
| SCHEMBL20574285 | 0.81 | LATS1 (0.59) | LATS1LATS2CYP3A4 | |
| SCHEMBL29650635 | 0.79 | LATS1 (0.56) | LATS1LATS2ACHE | |
| SCHEMBL4246335 | 0.76 | ACHE (0.70) | LATS1LATS2ACHEKDM4EPOLB | |
| SCHEMBL30309302 | 0.75 | LATS1 (1.00) | LATS1LATS2 | |
| SCHEMBL26177174 | 0.75 | LATS1 (1.00) | LATS1LATS2 | |
| SCHEMBL14006433 | 0.75 | CCR1 (0.53) | LATS1LATS2CYP3A4CYP1A2CYP2D6 | |
| SCHEMBL31375158 | 0.74 | LATS1 (0.60) | LATS1LATS2ACHEIMPDH2 | |
| SCHEMBL31375147 | 0.74 | LATS1 (0.60) | LATS1LATS2ACHE | |
| SCHEMBL20547736 | 0.73 | GABRG2 (0.43) | LATS1LATS2CYP3A4ACHEKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114621222-B | 6-6 Fused bicyclic heteroaryl compounds and their use as LATS inhibitors | 诺华股份有限公司 | 2024-12-17 | — | — | CN | disclosed |